DP Sports, Exercise and Health Science Questionbank
A.3. Non-nutritional ergogenic aids
Description
[N/A]Directly related questions
- 20N.3.SL.tz0.1a.iii: Comment on the statistical significance of the effect of the caffeine drink in this study.
- 20N.3.SL.tz0.1b: Outline two reasons for a placebo condition in the study.
-
20N.3.SL.tz0.1a.ii:
Calculate the difference in mean running distance, in metres, for the speed identified in 1(a)(i).
- 20N.3.SL.tz0.1a.i: Identify the running speed, in km h–1, at which the difference in running distance between the...
- 17N.3.SL.tz0.4b: Discuss why banned pharmacological substances should not be used by Olympic athletes.
-
17N.3.SL.tz0.4a:
Using an example, describe the placebo effect.
- 16M.3.SL.tz0.3a: List two classes of non-nutritional ergogenic aids that are currently banned by the International...
- 16M.3.SL.tz0.3c: Explain the proposed benefits to an athlete of using diuretics.
- 16M.3.SL.tz0.3b: State the adverse health effects of long-term use of anabolic steroids.
-
17M.3.SL.tz0.3c:
Discuss the benefits for athletes of using beta blockers.
- 16N.3.SL.tz0.3a: Define the term ergogenic aid.
- 17M.3.SL.tz0.3b: Outline two possible harmful effects of long term use of anabolic steroids.
- 17M.3.SL.tz0.3a: Define ergogenic aid.
- 16N.3.SL.tz0.3b: Discuss the benefits for an athlete using anabolic steroids.
- 18N.3.SL.tz0.4b: Evaluate the use of beta blockers by athletes.
- 18N.3.SL.tz0.4a: Define ergogenic aid.
-
19M.3.HL:.tz0.4:
Evaluate the use of caffeine by an athlete.
-
19M.3.SL.tz0.3a:
State two classes of non-nutritional ergogenic aids currently banned by the International Olympic Committee (IOC).
-
19M.3.SL.tz0.3b:
Evaluate the use of beta blockers by an archer to positively influence their performance.
-
19N.3.SL.tz0.4b:
Explain the use of erythropoietin (EPO) by a cross-country skier.
-
19N.3.HL:.tz0.3a:
Stimulants are one class of non-nutritional ergogenic aids currently banned by the International Olympic Committee (IOC). List two other classes of non-nutritional ergogenic aids that are banned.
-
19N.3.SL.tz0.4a:
Stimulants are one class of non-nutritional ergogenic aids currently banned by the International Olympic Committee (IOC). List two other classes of non-nutritional ergogenic aids that are banned.
- 19N.3.HL:.tz0.3b: Explain reasons for banning pharmacological substances.
Sub sections and their related questions
A.3.1. Define the term ergogenic aid.
- 17M.3.SL.tz0.3a: Define ergogenic aid.
- 16N.3.SL.tz0.3a: Define the term ergogenic aid.
- 18N.3.SL.tz0.4a: Define ergogenic aid.
A.3.2. Describe, with reference to an appropriate example, the placebo effect.
-
17N.3.SL.tz0.4a:
Using an example, describe the placebo effect.
- 20N.3.SL.tz0.1b: Outline two reasons for a placebo condition in the study.
A.3.3. List five classes of non- nutritional ergogenic aids that are currently banned by the International Olympic Committee (IOC) and the World Anti-Doping Agency (WADA).
- 16M.3.SL.tz0.3a: List two classes of non-nutritional ergogenic aids that are currently banned by the International...
-
19M.3.SL.tz0.3a:
State two classes of non-nutritional ergogenic aids currently banned by the International Olympic Committee (IOC).
-
19N.3.SL.tz0.4a:
Stimulants are one class of non-nutritional ergogenic aids currently banned by the International Olympic Committee (IOC). List two other classes of non-nutritional ergogenic aids that are banned.
-
19N.3.HL:.tz0.3a:
Stimulants are one class of non-nutritional ergogenic aids currently banned by the International Olympic Committee (IOC). List two other classes of non-nutritional ergogenic aids that are banned.
- 19N.3.HL:.tz0.3b: Explain reasons for banning pharmacological substances.
A.3.4. Discuss why pharmacological substances appear on the list of banned substances.
- 17N.3.SL.tz0.4b: Discuss why banned pharmacological substances should not be used by Olympic athletes.
-
19N.3.SL.tz0.4b:
Explain the use of erythropoietin (EPO) by a cross-country skier.
A.3.5. Discuss the proposed and actual benefits that some athletes would hope to gain by using anabolic steroids, erythropoietin (EPO), beta blockers, caffeine and diuretics.
- 16M.3.SL.tz0.3c: Explain the proposed benefits to an athlete of using diuretics.
-
17M.3.SL.tz0.3c:
Discuss the benefits for athletes of using beta blockers.
-
19M.3.SL.tz0.3b:
Evaluate the use of beta blockers by an archer to positively influence their performance.
-
19M.3.HL:.tz0.4:
Evaluate the use of caffeine by an athlete.
- 16N.3.SL.tz0.3b: Discuss the benefits for an athlete using anabolic steroids.
- 18N.3.SL.tz0.4b: Evaluate the use of beta blockers by athletes.
- 20N.3.SL.tz0.1a.i: Identify the running speed, in km h–1, at which the difference in running distance between the...
-
20N.3.SL.tz0.1a.ii:
Calculate the difference in mean running distance, in metres, for the speed identified in 1(a)(i).
- 20N.3.SL.tz0.1a.iii: Comment on the statistical significance of the effect of the caffeine drink in this study.
A.3.6. Outline the possible harmful effects of long-term use of anabolic steroids, EPO, beta blockers, caffeine and diuretics.
- 16M.3.SL.tz0.3b: State the adverse health effects of long-term use of anabolic steroids.
- 17M.3.SL.tz0.3b: Outline two possible harmful effects of long term use of anabolic steroids.
- 18N.3.SL.tz0.4b: Evaluate the use of beta blockers by athletes.
